COVID-19出院后残留肺部后遗症的薄层CT表现及纵向变化:短期随访研究
本研究纳入310例COVID-19患者,分为重症与非重症组,比较出院前及出院后不同时间段的薄层CT表现及纵向变化。结果显示重症组肺部后遗症更严重、恢复更慢,纤维化样病变完全吸收率在重症组为24.3%(17/70)、非重症组为52.0%(53/102)。最常见的纤维化样表现为实质带,支气管扩张在重症组各阶段保持相对稳定的中等水平(范围31.6%至47.8%)。
要点
- 重症/危重症COVID-19患者出院后肺部后遗症更严重且恢复更慢。
- 纤维化样病变在短期随访中可完全吸收:重症组至少17/70(24.3%),非重症组53/102(52.0%)。
- 最常见的纤维化样表现为实质带;不规则界面为非特异性征象;重症组支气管扩张比例各阶段保持相对稳定中等水平(范围31.6%至47.8%)。
关键影像表现/征象
- 磨玻璃影(GGO)合并实变在两组中于T1明显下降,之后维持相似较低水平。
- 重症组GGO在T1先呈上升趋势、至T4下降,而非重症组GGO发生率逐渐下降。
- 多数纤维化样表现呈先快速下降后保持稳定的趋势。
- 重症组支气管扩张持续处于中等水平。
- 最常见的纤维化样表现为实质带,不规则界面为COVID-19的非特异性征象。
诊断标准与关键数值
- 纤维化样病变完全吸收率:重症组24.3%(17/70),非重症组52.0%(53/102)。
- 重症组支气管扩张比例在各阶段保持相对稳定的中等水平,范围31.6%至47.8%。
临床应用与阅片要点
- 随访阅片时应关注GGO、实变及纤维化样表现(如实质带)的纵向变化,重症组恢复更慢。
- 重症组支气管扩张比例在各阶段保持相对稳定中等水平(范围31.6%至47.8%),阅片时需注意评估。
- 不规则界面为COVID-19非特异性征象,鉴别诊断时需结合其他表现。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study analyzed and compared CT findings and longitudinal variations after discharge between severe and non-severe coronavirus disease (COVID-19) patients who had residual pulmonary sequelae at pre-discharge.
METHODS: A total of 310 patients were included and stratified into severe and non-severe COVID-19 groups. Cross-sectional CT features across different time periods (T0: pre-discharge, T1: 1-4 weeks after discharge, T2: 5-8 weeks after discharge, T3: 9-12 weeks after discharge, T4: > 12 weeks after discharge) were compared, and the longitudinal variations of CT findings were analyzed and compared in both groups.
RESULTS: The cumulative absorption rate of fibrosis-like findings in the severe and non-severe groups at T4 was 24.3% (17/70) and 52.0% (53/102), respectively. In both groups, ground-glass opacity (GGO) with consolidation showed a clear decreasing trend at T1, after which they maintained similar lower levels. The GGO in the severe group showed an increasing trend first at T1 and then decreasing at T4; however, the incidence decreased gradually in the non-severe group. Most fibrosis-like findings showed a tendency to decrease rapidly and then remained stable. Bronchial dilatation in the severe group persisted at an intermediate level.
CONCLUSIONS: After discharge, the characteristics and changing trends of pulmonary sequelae caused by COVID-19 were significantly different between the two groups. Pulmonary sequelae were more serious and recovery was slower in patients with severe/critical disease than in patients with moderate disease. A portion of the fibrosis-like findings were completely absorbed in patients with moderate and severe/critical diseases.
KEY POINTS: • Lung sequelae were more serious and recovery was slower in severe/critical COVID-19 patients. • Complete absorption of fibrosis-like findings after a short-term follow-up was observed in at least 17/70 (24.3%) of COVID-19 patients with severe/critical disease and 53/102 (52.0%) of COVID-19 patients with moderate disease. • The most common fibrosis-like findings was a parenchymal band; irregular interface was a nonspecific sign of COVID-19, and the percentage of bronchial dilatation in patients with severe/critical disease remained at a relatively stable medium level (range, 31.6 to 47.8%) at all stages.
引用
- Zhang D, Zhang C, Li X, et al. Thin-section computed tomography findings and longitudinal variations of the residual pulmonary sequelae after discharge in patients with COVID-19: a short-term follow-up study. Eur Radiol. 2021. PMID: 33704519. doi:10.1007/s00330-021-07799-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。